ReviewJournal of racial and ethnic health disparities2025
Management of Type 2 Diabetes Mellitus in Native Americans and Alaska Natives: A Systematic Review.
Review in Journal of racial and ethnic health disparities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
American Indian and Alaska Native (AI/AN) populations face a disproportionately high prevalence of type 2 diabetes mellitus (T2DM) compared to other U.S. racial and ethnic groups. Despite this burden, limited literature exists on effective, culturally sensitive interventions, highlighting a critical need for focused research in this population. This systematic review examines 28 studies on how self-management, clinical management, and community-based programs improve glycemic control, medication adherence, and patient engagement in AI/AN populations. Clinical management reveals widespread use of metformin but limited initiation of newer agents such as Sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists. Interventions integrating traditional practices and community engagement consistently yielded better diabetes outcomes. Effective T2DM management in AI/AN populations depends on culturally sensitive, community-based approaches that enhance adherence and clinical outcomes. While clinical care evolves, incorporating culturally grounded strategies alongside optimized pharmacotherapy is essential. Future efforts should focus on integrated care models that respect cultural values and support long-term management to reduce diabetes disparities.
Indexed as
Identifiers
40971128What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.